Morgan Stanley Soleno Therapeutics Inc Transaction History

Morgan Stanley

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.14 - $0.23 $6 - $9	-43 Closed	0 $0
Q1 2022 Oct 27, 2022	BUY	$0.22 - $0.47 $9 - $20	43 New	43 $0
Q1 2022 May 13, 2022	SELL	$0.22 - $0.47 $61 - $131	-279 Reduced 86.65%	43 $0
Q4 2021 Feb 14, 2022	SELL	$0.41 - $0.91 $111 - $247	-272 Reduced 45.79%	322 $0
Q3 2021 Nov 15, 2021	BUY	$0.8 - $1.12 $475 - $665	594 New	594 $0

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $441M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.